Original Source Material
Goal Is for Faster, Better Treatment Innovation, Drug Therapies The U.S. Food and Drug Administration is planning to launch a pilot program aimed at advancing real-time clinical trials through the use of artificial intelligence tools and data science. The goal is to accelerate the development of promising new drugs, which often end up slowed down in bottlenecks.